A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma

Lung adenocarcinoma is one of the most malignant diseases worldwide. The immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) and programmed cell death-ligand 1 (PD-L1) have changed the paradigm of lung cancer treatment; however, there are still patients who are resistant. F...

Full description

Bibliographic Details
Main Authors:	Yujia Zheng, He Tian, Zheng Zhou, Chu Xiao, Hengchang Liu, Yu Liu, Liyu Wang, Tao Fan, Bo Zheng, Fengwei Tan, Qi Xue, Gengshu Gao, Chunxiang Li, Jie He
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	lung adenocarcinoma immune infiltration prognosis immunotherapy risk prediction model signature
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.651406/full

Similar Items

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
by: Sijin Sun, et al.
Published: (2021-03-01)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
by: Taohua Yue, et al.
Published: (2021-08-01)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
by: Sijin Sun, et al.
Published: (2020-08-01)

Prognostic value of tumor immune cell infiltration patterns in colon adenocarcinoma based on systematic bioinformatics analysis
by: Hao Xu, et al.
Published: (2021-07-01)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
by: Yang Cheng, et al.
Published: (2021-06-01)

Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy
by: Xiaodong Yang, et al.
Published: (2021-06-01)

Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis
by: Zhengliang Tu, et al.
Published: (2021-04-01)

Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma
by: Lulu He, et al.
Published: (2020-12-01)

Development and Validation of a Prognostic Autophagy-Related Gene Pair Index Related to Tumor-Infiltrating Lymphocytes in Early-Stage Lung Adenocarcinoma
by: Zi-Hao Wang, et al.
Published: (2021-09-01)

TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma
by: Longbin Guo, et al.
Published: (2020-09-01)

Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing immune lymphocyte infiltration
by: Yan-Qi Li, et al.
Published: (2021-04-01)

Characterization of lncRNA-Associated ceRNA Network to Reveal Potential Prognostic Biomarkers in Lung Adenocarcinoma
by: Yang Wang, et al.
Published: (2020-04-01)

A Prognostic Nomogram Combining Immune-Related Gene Signature and Clinical Factors Predicts Survival in Patients With Lung Adenocarcinoma
by: Congkuan Song, et al.
Published: (2020-08-01)

Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma
by: Xiaodong Yang, et al.
Published: (2019-07-01)

Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer
by: Jingjing Song, et al.
Published: (2020-07-01)

High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma
by: Feng Jiang, et al.
Published: (2021-07-01)

Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma
by: Zhan-yu Xu, et al.
Published: (2020-07-01)

Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction
by: Xin Hu, et al.
Published: (2021-05-01)

DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma
by: Yang-Jie Wu, et al.
Published: (2021-09-01)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
by: Chenhao Zhou, et al.
Published: (2019-11-01)

Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma
by: Tingting Bian, et al.
Published: (2021-03-01)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
by: Guomin Wu, et al.
Published: (2021-07-01)

Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma
by: Cheng Yue, et al.
Published: (2019-11-01)

A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma
by: Xuelong Wang, et al.
Published: (2021-07-01)

A two-microRNA signature as a diagnostic and prognostic marker of pancreatic adenocarcinoma
by: Yu Y, et al.
Published: (2018-06-01)

Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
by: Qiuxian Zheng, et al.
Published: (2021-06-01)

An expression signature model to predict lung adenocarcinoma-specific survival
by: Shi X, et al.
Published: (2018-09-01)

The correlation of WDR76 expression with survival outcomes and immune infiltrates in lung adenocarcinoma
by: Likui Fang, et al.
Published: (2021-10-01)

Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor‐infiltrating immune cell analysis
by: Yi Wan, et al.
Published: (2021-06-01)

Signature identification of relapse-related overall survival of early lung adenocarcinoma after radical surgery
by: Peng Han, et al.
Published: (2021-08-01)

The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma
by: Yu Liu, et al.
Published: (2020-02-01)

Exonuclease 1 (EXO1) is a Potential Prognostic Biomarker and Correlates with Immune Infiltrates in Lung Adenocarcinoma
by: Zhou CS, et al.
Published: (2021-02-01)

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-05-01)

Upregulation of ADAM12 Is Associated With a Poor Survival and Immune Cell Infiltration in Colon Adenocarcinoma
by: Zigao Huang, et al.
Published: (2021-09-01)

Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma
by: Rui Mao, et al.
Published: (2021-02-01)

AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma
by: Chenxi Ma, et al.
Published: (2020-12-01)

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma
by: Dina Guo, et al.
Published: (2020-03-01)

Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer
by: Yang Peng, et al.
Published: (2021-04-01)

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma
by: Nian Liu, et al.
Published: (2020-08-01)

Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma
by: Jie Yao, et al.
Published: (2021-07-01)